Safety, Tolerability, Pharmacokinetics and Immunogenicity Study of GB002 Recombinant Peptide Inhalation Solution in Healthy Subjects
Clinical trial NCT06423261 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06423261
- Sponsor
- Zhejiang Echon Biopharm Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-24
- Primary completion
- 2025-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.